TY  - GEN
AU  - Thomson,A B
AU  - Wright,J P
AU  - Vatn,M
AU  - Bailey,R J
AU  - Rachmilewitz,D
AU  - Adler,M
AU  - Wilson-Lynch,K A
TI  - Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease
SN  - 0269-2813
PY  - 1996///1112
KW  - Adult
KW  - Aged
KW  - Aminosalicylic Acids
KW  - adverse effects
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - therapeutic use
KW  - Canada
KW  - Colitis
KW  - drug therapy
KW  - Crohn Disease
KW  - Double-Blind Method
KW  - Europe
KW  - Female
KW  - Humans
KW  - Ileitis
KW  - Male
KW  - Mesalamine
KW  - Middle Aged
KW  - South Africa
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2036.1995.tb00438.x
ER  -